has been cited by the following article(s):
[1]
|
3-(Bromoacetyl) coumarin is a potential therapeutic agent against neonatal sepsis-associated Pseudomonas extremorientalis
Archives of Microbiology,
2023
DOI:10.1007/s00203-023-03653-2
|
|
|
[2]
|
Neonatal Sepsis and Associated Factors Among Newborns in Woldia and Dessie Comprehensive Specialized Hospitals, North-East Ethiopia, 2021
Infection and Drug Resistance,
2022
DOI:10.2147/IDR.S374835
|
|
|
[3]
|
Bacterial etiology and risk factors among newborns suspected of sepsis at Hawassa, Ethiopia
Scientific Reports,
2022
DOI:10.1038/s41598-022-24572-0
|
|
|